Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 37.85% | 37.60% | 28.86% | 28.78% | 37.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.85% | 37.60% | 28.86% | 28.78% | 37.40% |
| Cost of Revenue | 24.36% | 24.13% | 35.45% | 35.36% | 55.75% |
| Gross Profit | 51.70% | 51.42% | 23.59% | 23.52% | 22.58% |
| SG&A Expenses | 28.11% | 27.87% | 13.65% | 13.58% | 20.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.70% | 1.88% | 41.81% | 41.85% | -11.96% |
| Total Operating Expenses | 26.34% | 26.11% | 23.55% | 23.48% | 51.19% |
| Operating Income | 1,737.90% | 1,734.42% | 107.49% | 107.37% | -90.50% |
| Income Before Tax | 933.84% | 931.93% | 125.38% | 125.25% | 104.98% |
| Income Tax Expenses | 413.07% | 412.12% | -0.37% | -0.42% | 109.78% |
| Earnings from Continuing Operations | 1,539.58% | 1,537.36% | 163.14% | 163.00% | 96.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,000.91% | 998.48% | 259.26% | 259.14% | -47.24% |
| Net Income | 5,193.82% | 5,191.37% | 288.72% | 288.49% | 102.55% |
| EBIT | 1,737.90% | 1,734.42% | 107.49% | 107.37% | -90.50% |
| EBITDA | 306.37% | 305.60% | 25.18% | 25.10% | -78.10% |
| EPS Basic | 3,200.00% | 3,200.00% | 300.00% | 300.00% | 104.00% |
| Normalized Basic EPS | 6,300.00% | 6,200.00% | 284.62% | 284.62% | -105.26% |
| EPS Diluted | 3,200.00% | 3,200.00% | 300.00% | 300.00% | 104.00% |
| Normalized Diluted EPS | 6,300.00% | 6,200.00% | 284.62% | 284.62% | -105.26% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 166.67% | 166.67% | 160.00% | 160.00% | -53.85% |
| Payout Ratio | -0.95% | -0.95% | -0.74% | -0.74% | -- |